Universal prescription drug coverage in Canada
Open Access
- 15 October 2016
- journal article
- review article
- Published by SAGE Publications in Healthcare Management Forum
- Vol. 29 (6), 247-254
- https://doi.org/10.1177/0840470416658907
Abstract
Canada’s universal public healthcare system is unique among developed countries insofar as it does not include universal coverage of prescription drugs. Universal, public coverage of prescription drugs has been recommended by major national commissions in Canada dating back to the 1960s. It has not, however, been implemented. In this article, we extend research on the failure of early proposals for universal drug coverage in Canada to explain failures of calls for reform over the past 20 years. We describe the confluence of barriers to reform stemming from Canadian policy institutions, ideas held by federal policy-makers, and electoral incentives for necessary reforms. Though universal “pharmacare” is once again on the policy agenda in Canada, arguably at higher levels of policy discourse than ever before, the frequently recommended option of universal, public coverage of prescription drugs remains unlikely to be implemented without political leadership necessary to overcome these policy barriers.Keywords
This publication has 41 references indexed in Scilit:
- Stitching the gaps in the Canadian public drug coverage patchwork? A review of provincial pharmacare policy changes from 2000 to 2010Health Policy, 2012
- The effect of cost on adherence to prescription medications in CanadaCMAJ : Canadian Medical Association Journal, 2012
- Lobbying, Campaign Contributions, and Health Care ReformNew England Journal of Medicine, 2009
- Effects of Prescription Coinsurance and Income-Based Deductibles on Net Health Plan Spending for Older Users of Inhaled MedicationsMedical Care, 2009
- Toward an Understanding of High Performance Pharmaceutical Policy Systems: A “Triple-A” Framework and Example AnalysisThe Open Health Services and Policy Journal, 2009
- Cost-related prescription nonadherence in the united states and Canada: A system-level comparison using the 2007 international health policy survey in seven countriesClinical Therapeutics, 2009
- Emergency hospital admissions after income-based deductibles and prescription copayments in older users of inhaled medicationsClinical Therapeutics, 2008
- A cross-national study of prescription nonadherence due to cost: Data from the joint Canada-United States survey of healthClinical Therapeutics, 2006
- The Common Drug Review: A NICE start for Canada?Health Policy, 2006
- Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthmaClinical Therapeutics, 2006